CD4-Based Chimeric Antigen Receptor (CAR)-T Cells With Resistance to HIV-1 Infection and Enhanced Anti-HIV Efficacy: Covalent Interaction Between CD4-CAR and HIV-1 Envelope Glycoprotein.

J Med Virol · 2026 · PMC12933161 · PMID 41736532

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In addition, D1C‐BB CD8+ CAR‐T cells were significantly more abundant in the spleens of treated mice at day 18, whereas CD4+ CAR‐T cell levels did not reach statistical significance (Figure 4G ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.